Phase II study of cetuximab (Erbitux) in patients with progressive or recurrent endometrial cancer.
Phase of Trial: Phase II
Latest Information Update: 05 Sep 2012
At a glance
- Drugs Cetuximab (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 23 Jan 2012 Additional lead trial investigator (Judith Wolf, MD) identified as reported by ClinicalTrials.gov.
- 22 Feb 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.